Stock Comparison
ABBV vs JNJ
AbbVie Inc and Johnson & Johnson side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$447.62B
$613.02B
P/E (TTM)
123.6
29.5
Forward P/E
17.8
22.0
Price/Sales
7.1
6.4
Price/Book
50.5
7.6
EV/EBITDA
30.2
19.2
Dividend Yield
2.77%
2.12%
Profitability
Net Margin
5.79%
21.80%
Operating Margin
32.20%
27.40%
Return on Equity
62.30%
26.40%
Return on Assets
10.00%
8.42%
Growth (YoY)
Revenue Growth
12.40%
9.90%
Earnings Growth
-46.20%
-52.90%
Price & Risk
Beta
0.3
0.3
52-Week High
$253.35
$255.11
52-Week Low
$176.02
$147.81
Analyst Target
$254.38
$257.32
Compare ABBV and JNJ your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.